Drug shortage: Propranolol Hydrochloride Injection (PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL)
FDA lists 2 presentations as Current. Availability: Unavailable (2). Reason: Shortage of an active ingredient; Delay in shipping of the drug. Companies: Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC.
- Published by source
- 2023-10-31
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Products
- Propranolol Hydrochloride Injection PROPRANOLOL HYDROCHLORIDE PROPRANOLOL
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD
- Next release: November 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-10-31
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #989 | new | 2026-10-22 | ec96c03600ca…31df98 | 845931a3b291…0a59d7 |
Chain head: #1076 8ad5adc30b9b…88ce20